Asia Pacific Theranostics Market, By Product Type (Diagnostic Imaging, Radiopharmaceuticals, In-vitro diagnostics (IVD)/biomarkers Screening and Software and services), By Application, By End-User, By Country - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Asia Pacific Theranostics Market size was valued at USD 493.40 million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032
Theranostics, an integration of precisely targeted therapies and specialized diagnostics, represents an emerging domain within the realm of drug discovery. Its primary objective is to facilitate the early detection and treatment of both primary tumors and metastases. The various methodologies explored in this study elucidate recent advancements in their application and underscore their substantial potential for further research and development. By employing theranostics, they move one step closer to utilizing the mentioned carriers as a preferred approach for delivering active substances, specifically targeting the treatment site while also monitoring the treatment\'s efficacy. This theranostics strategy offers numerous significant advantages over conventional non-targeted chemotherapy drugs.
Asia Pacific Theranostics Market- Market Dynamics
The prevalence of chronic diseases like cancer, cardiovascular diseases, and neurological disorders is expected to drive the growth of the market
The Asia Pacific region exhibits some of the highest cancer rates globally, especially in nations such as China, Japan, and India. This prevalence underscores the need for advanced diagnostic and therapeutic solutions. Personalized cancer treatment, facilitated by theranostics, is pivotal in identifying the most suitable therapies based on individual tumor characteristics, ultimately improving patient outcomes and minimizing side effects. Recent epidemiological data reveals that China alone sees over 2.2 million new cancer cases annually, with 1.4 million in men and 0.8 million in women, resulting in approximately 1.6 million cancer-related deaths. Moreover, the expansion of healthcare infrastructure in developing economies is creating new market opportunities, although limited awareness and expertise may impede market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Bayer AG
GE Healthcare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX Advanced Biochemical Compounds GmbH
Others
ASIA PACIFIC THERANOSTICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
Diagnostic Imaging
Radiopharmaceuticals
In-vitro diagnostics (IVD)/biomarkers Screening
Software and services
ASIA PACIFIC THERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Prostate Cancer
Neuroendocrine Cancer
Adult Pheochromocytoma
Others
ASIA PACIFIC THERANOSTICS MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
Hospitals and Cancer Care Centers
Theranostics Centers
Research and Academic Centers
ASIA PACIFIC THERANOSTICS MARKET, BY COUNTRY- MARKET ANALYSIS, 2019 - 2032
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
TABLE OF CONTENT
1. Asia Pacific Theranostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Asia Pacific Theranostics Market Snippet by Product Type
2.1.2. Asia Pacific Theranostics Market Snippet by Application
2.1.3. Asia Pacific Theranostics Market Snippet by End-User
2.1.4. Asia Pacific Theranostics Market Snippet by Country
2.2. Competitive Insights
3. Asia Pacific Theranostics Key Market Trends
3.1. Asia Pacific Theranostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Asia Pacific Theranostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Asia Pacific Theranostics Market Opportunities
3.4. Asia Pacific Theranostics Market Future Trends
4. Asia Pacific Theranostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Asia Pacific Theranostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Asia Pacific Theranostics Market Landscape
6.1. Asia Pacific Theranostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Asia Pacific Theranostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
7.1.2. Diagnostic Imaging
7.1.3. Radiopharmaceuticals
7.1.4. In-vitro diagnostics (IVD)/biomarkers Screening
7.1.5. Software and services
8. Asia Pacific Theranostics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Prostate Cancer
8.1.3. Neuroendocrine Cancer
8.1.4. Adult Pheochromocytoma
8.1.5. Others
9. Asia Pacific Theranostics Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
9.1.2. Hospitals and Cancer Care Centers
9.1.3. Theranostics Centers
9.1.4. Research and Academic Centers
10. Asia Pacific Theranostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. Asia Pacific (APAC)
10.2.1. Overview
10.2.2. Asia Pacific Theranostics Key Manufacturers in Asia Pacific
10.2.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.7. India
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.8. China
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.9. Japan
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.10. South Korea
10.2.10.1. Overview
10.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.11. Australia
10.2.11.1. Overview
10.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.12. Thailand
10.2.12.1. Overview
10.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.13. Indonesia
10.2.13.1. Overview
10.2.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.14. Philippines
10.2.14.1. Overview
10.2.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.15. Rest of APAC
10.2.15.1. Overview
10.2.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Asia Pacific Theranostics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Bayer AG
11.2.2. GE HealthCare Technologies, Inc.
11.2.3. Siemens Healthineers AG (Siemens AG)
11.2.4. Cardinal Health, Inc.
11.2.5. Canon, Inc.
11.2.6. Clarity Pharmaceuticals Ltd
11.2.7. Koninklijke Philips N.V.
11.2.8. Thermo Fisher Scientific, Inc.
11.2.9. Telix Pharmaceuticals Limited
11.2.10. ABX advanced biochemical compounds GmbH
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
